Optimization of preparation technology and in vitro release of baicalin-glycyrrhizic acid solid nanocrystals
- VernacularTitle:黄芩苷-甘草酸纳米晶的制备工艺优化及体外释放考察
- Author:
Long XIE
1
;
Yuxin ZHAO
1
;
Kai LIU
1
;
Huan GU
1
;
Xiaofang LI
2
Author Information
1. State Key Laboratory of Southwestern Chinese Medicine Resources，Chengdu University of Traditional Chinese Medicine，Chengdu 611137，China;School of Pharmacy，Chengdu University of Traditional Chinese Medicine，Chengdu 611137，China
2. State Key Laboratory of Southwestern Chinese Medicine Resources，Chengdu University of Traditional Chinese Medicine，Chengdu 611137，China
- Publication Type:Journal Article
- Keywords:
couplet medicinals of Scutellaria baicalensis-Glycyrrhiza uralensis;
baicalin;
glycyrrhizic acid;
nanocrystals;
in
- From:
China Pharmacy
2023;34(23):2829-2834
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE To optimize the preparation technology of baicalin （BCN）-glycyrrhizic acid （GA） solid nanocrystals （BCN-GA-SN）， to characterize them and investigate their in vitro release characteristics. METHODS According to the compatibility ratio of classic couplet medicinals “Scutellaria baicalensis-Glycyrrhiza uralensis”， the compatibility ratio of BCN and GA was determined as 6∶1 （m/m）； BCN-GA nanosuspension was prepared by precipitation method combined with high-pressure homogenization method. The preparation technology of BCN-GA nanosuspension was optimized by using mean particle size and polydispersity index （PDI） as indexes and with types and dosage of stabilizers， stirring speed and time， high-pressure homogenization pressure and frequency as factors. The freeze-dried consolidation process of BCN-GA nanosuspension was optimized to prepare BCN-GA-SN using average particle size， PDI and redispersibility index （RDI） as indicators， with the type and dosage of freeze-dried protective agents as factors； then， the physicochemical properties and in vitro release of BCN-GA-SN were investigated. RESULTS The optimal preparation technology of BCN-GA-SN was as follows： BCN-GA nanosuspension was prepared by using 15% sodium dodecyl sulfate as a stabilizer， stirring at 1 000 r/min for 15 minutes， and homogenizing at 100 MPa for 20 times； then， BCN-GA nanosuspension was freeze-dried and solidified with 5% mannitol （corresponding to the dosage of BCN）. The average particle size of prepared BCN-GA-SN was （442.2±5.7） nm with PDI of 0.225±0.015 and RDI of 1.055± 0.013. The prepared BCN-GA-SN presented as the irregularly spherical shape with more uniform size； the drug-loading amount of BCN in the nanocrystal was （62.5±0.7）%， and that of GA was （9.4±0.2）%； the in vitro release results showed that the cumulative dissolution of BCN-GA-SN was higher than that of the physical mixture of BCN and GA. CONCLUSIONS BCN-GA-SN is prepared successfully in this study with uniform particle size and even distribution， which can effectively improve the dissolution of BCN.
